Analyst Ratings for Acorda Therapeutics Inc. (ACOR)Updated: 2017-07-27
Shares of Acorda Therapeutics Inc. (NASDAQ:ACOR) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for ACOR last month.
8 analysts issued ratings on the stock, where 2 gave ACOR a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
ACOR was given price targets by several analysts. The maximum price target given was 35, implying a possible profit of 61.29 percent. The minimum price target given was 17, which equates to a potential downside of -21.66 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
Analysts have revised their earnings estimates upwards for this quarter, by about 3.15 percent on average, compared to last month. That number becomes 75.62 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 2.05 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 26.1 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 1 analysts have revised their quarterly estimates upwards in the past 30 days, while 2 analysts made negative revisions. Also over the last month, 1 analysts increased their estimates for the FY earnings, while 2 analysts made negative revisions to their fiscal year's estimates.
ACOR has traded between a high of 33.00 and a low of 13.60 over the past year. Currently the stock is 59.56 percent higher than its low, and 34.24 percent lower than its 52-week high. ACOR has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The ACOR value stock report compares ACOR to some of its peers using value stock charts. The market cap of ACOR is $1.05 billion. ACOR's next earnings release will be on 0000-00-00, which is days away.